THY1 and neoplasm: The mesenchymal marker CD90, a glycoprotein known to be expressed in glioblastoma and associated with an adhesion/migration gene signature and invasive tumor features (43, 44, 64), was upregulated in the pontine tumor, regardless the molecular alterations.